Versant Venture Management, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$7,602,350
-5.7%
5,068,2330.0%4.04%
-57.7%
Q2 2023$8,058,490
+121.6%
5,068,2330.0%9.56%
+26.1%
Q1 2023$3,635,950
+23.8%
5,068,2330.0%7.58%
+24.7%
Q4 2022$2,937,041
-39.0%
5,068,2330.0%6.08%
-26.0%
Q3 2022$4,815,000
-20.8%
5,068,2330.0%8.21%
-12.0%
Q2 2022$6,082,000
-8.4%
5,068,2330.0%9.32%
+40.7%
Q1 2022$6,639,000
-25.6%
5,068,2330.0%6.63%
+38.9%
Q4 2021$8,920,000
-18.9%
5,068,2330.0%4.77%
+4.8%
Q3 2021$10,998,000
-38.0%
5,068,2330.0%4.55%
-22.5%
Q2 2021$17,739,000
-64.5%
5,068,2330.0%5.88%
-39.6%
Q1 2021$49,973,000
-7.9%
5,068,233
+1.3%
9.74%
+72.8%
Q4 2020$54,242,000
-24.8%
5,003,892
-28.6%
5.63%
-57.3%
Q3 2020$72,140,000
-100.0%
7,003,8920.0%13.20%
-37.2%
Q2 2020$146,241,265,000
+111.8%
7,003,892
-0.9%
21.01%
+10.9%
Q1 2020$69,056,636,0007,068,23318.94%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders